Christine Blank, Contributing Editor
Many Health-Care Groups Laud Generics Bill
Nearly 20 health-care organizations and PBMs come out in favor of FAST Generics Act.
How Pill Bottles Can Deter Opioid Misuse and Abuse
How Pill Bottles Can Deter Opioid Misuse and Abuse
Special pill bottle caps can help reduce medication misuse and abuse.
Potential blockbuster arthritis drug delayed
Citing safety concerns, FDA delayed approval of a new blockbuster drug to treat rheumatoid arthritis.
Novel drug approved for Huntington's symptom
FDA recently approved deutetrabenazine (Austedo, Teva Pharmaceuticals) to treat chorea associated with Huntington’s disease (HD). The medication is only the second product approved to treat HD, and is the first deuterated product approved by FDA.
Hep C drugs approved for kids
FDA approved supplemental applications for 2 primary hepatitis C medications to be used in children for the first time.
Pharmacists Are Central to Supervalu Diabetes Campaign
Supervalu’s diabetes campaign offers risk assessments, screening, and food education.
Study: New Diabetes Drug Class Reduces Heart Deaths
New class of glucose-lowering agents lowers hospitalization and death rates even in Type 2 patients without heart disease.
First progressive MS drug carries high price tag
While FDA just approved the first drug for primary progressive multiple sclerosis (PPMS), the drug’s price tag is controversial.
Major EpiPen recall issued
Meridian Medical Technologies, Mylan's manufacturing partner for the EpiPen Auto-Injector, expanded a voluntary recall of the EpiPen and EpiPen Jr. epinephrine auto-Injectors to now include additional lots distributed in the United States and other markets.
First drug for rare skin cancer wins approval
FDA approved the first treatment for metastatic Merkel cell carcinoma (MCC), a rare, aggressive skin cancer.


View Results